Relation of antimullerian hormone with the clinical signs of hyperandrogenism and polycystic ovary morphology

The relation of antimullerian hormone (AMH) levels with the clinical and biochemical markers of polycystic ovary syndrome (PCOS) could be different. A total of 463 PCOS patients were evaluated in this cross-sectional study. Groups were constructed according to polycystic ovarian morphology (PCOM) and menstrual cycle-length. The relation of serum AMH with androgenic hormones, menstrual cycle-length and clinical signs of PCOS were investigated. A powerful positive relation was found between the PCOM and AMH levels (odds ratio?=?2.49). There was a negative correlation between age and AMH level (p?r[correlation coefficent]?=??0.155). Positive correlations were found between luteinizing hormone (LH) and AMH (p?r?=?0.25) and also between cycle length and AMH (p?r?=?0.27). We found a negative week correlation between AMH and follicle-stimulating hormone (FSH) (p?=?0.01, r?=??0.19). After controlling main androgenic hormones, AMH was found to be correlated with the Ferriman–Gallway score (p?=?0.03, r?=?0.18). There was a positive relationship between hirsutism and AMH (odds ratio?=?1.43), but no correlation between AMH and other parameters of clinical hyperandrogenism like hair-loss, acne and seborrhea were identified. The strongest relation was presented between the AMH levels and PCOM. Also, cycle-length correlated well with the AMH levels. The relationship between hirsutism and AMH is found to be independent from androgenic hormones.